Get Lantus SoloStar News on Telangana Today, Lantus SoloStar latest news, Lantus SoloStar news, | Telangana Today ...

Biocon shares trade near a 52-week high as its Malaysia unit wins EMA approval for Semglee production; read what’s next for ...

Biocon received approval from the European Medicines Agency (EMA) for a new drug product fill finish line for Semglee ...

Biocon founder Kiran Mazumdar-Shaw on Wednesday told CNBC-TV18 at the Future Female Forward event, that the company has put ...

Biocon's Malaysia unit received European Medicines Agency approval for a new drug product fill finish line for Semglee ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

Biocon shares surged over 8% to a 52-week high after reports said promoter-group entity Mylan exited the company through a ₹3,480-crore block deal. Investors also tracked the company's recent Malaysia ...

A once-weekly insulin injection is an exciting development in diabetes care, but is it automatically better for everyone?

India: Awiqli (insulin icodec), a once-weekly basal insulin injection for adults with type 1 and type 2 diabetes, has been ...

A 400-participant trial found long-acting insulin glargine reduced dangerous low blood sugar and nighttime hypoglycemia in ...

Novo Nordisk launches once-weekly basal insulin Awiqli in India: Our Bureau, Mumbai Friday, July 10, 2026, 14:15 Hrs [IST] Novo Nordisk India announced the launch of Awiqli (insul ...

Danish pharmaceutical company Novo Nordisk has launched the world's first once-weekly basal insulin, Awiqli (insulin icodec), ...